Free Delivery Over $100
|
|
|||
|
||||
OverviewFull Product DetailsAuthor: Yui-Wing Francis Lam (Professor of Pharmacology, Minnie Stevens Piper Professor, James O'Burke Endowed Centennial Fellow in Pharmacy, University of Texas Health Science Center, San Antonio, TX, USA) , Scott R. Stuart, MD (Associate Professor, Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, NY, USA)Publisher: Elsevier Science Publishing Co Inc Imprint: Academic Press Inc Edition: 2nd edition ISBN: 9780128126264ISBN 10: 0128126264 Pages: 544 Publication Date: 05 December 2018 Audience: Professional and scholarly , Professional & Vocational Format: Hardback Publisher's Status: Forthcoming Availability: Not yet available  This item is yet to be released. You can pre-order this item and we will dispatch it to you upon its release. Table of Contents1. Principles of Pharmacogenomics: Pharmacokinetic, Pharmacodynamic, and Clinical Implications 2. Governmental and Academic Efforts to Advance the Field of Pharmacogenomics 3. Incorporating Pharmacogenomics in Drug Development: Industry and Regulatory Perspectives 4. Translating Pharmacogenomic Research to Therapeutic Potentials 5. Pharmacogenomics in Cancer Therapeutics 6. Pharmacogenomics in Cardiovascular Diseases 7. Pharmacogenomics in Psychiatry Disorders 8. Role of Pharmacogenomics in HIV Infection 9. Role of Pharmacogenomics in Diabetes 10. A Look to the Future: Pharmacogenomics, Pharmacoepigenomics, and System Biology - Data Technologies of Today and Tomorrow 11. The Importance of Ethnicity Definitions and Pharmacogenomics in Ethnobridging and Pharmacovigilance 12. Pharmacogenomics in Latin American Population 13. Reactive, Point-of-Care, Pre-emptive and Direct-to-Consumer Pharmacogenomic Testing 14. Economic Evaluation of Pharmacogenomic Testing: Lessons from Psychiatric Pharmacogenomics 15. Pharmacogenomics Education and Clinical Practice GuidelinesReviewsAuthor InformationDr. Lam is Professor of Pharmacology at the University of Texas Health Science Center San Antonio (UTHSCSA). His editing experience included the first edition of Pharmacogenomics as well as being the lead editor of another published book entitled Herbal Supplements - Drug Interactions. Scientific and Regulatory Perspectives . He is also a co-author for a book chapter on pharmacogenetics in six consecutive editions of the textbook Pharmacotherapy: A Pathophysiologic Approach . Dr. Lam designed and continues to direct a graduate course Molecular and Pharmacological Basis of Therapeutics since 2002 for the UTHSCSA and the College of Pharmacy at the University of Texas at Austin. He has organized and participated in international and national symposia on topics related to personalized and molecular medicine, and is a scientific councilor for the Pacific Rim Association for Clinical Pharmacogenetics. Dr. Stuart Scott will take on the co-editor role for this second edition. Dr. Scott is an Assistant Professor in the Department of Genetics and Genomic Sciences at the Icahn School of Medicine at Mount Sinai, New York, where he oversees clinical pharmacogenetic testing as an ABMGG-certified Director of the Mount Sinai Genetic Testing Laboratory. His research interests include cardiovascular pharmacogenomics, multiethnic pharmacogenomic allele discovery, and long-read sequencing method development. He has co-authored Clinical Pharmacogenetics Implementation Consortium (CPIC) practice guidelines and is a member of other international genomics/pharmacogenomics consortia, and is a co-investigator of the Institute for Personalized Medicine (IPM) pharmacogenomics implementation program at Mount Sinai. He teaches pharmacogenetics to medical, graduate and genetic counseling students, clinical residents and fellows, and co-directs the comprehensive Translational Genomics graduate level course at Mount Sinai. Tab Content 6Author Website:Countries AvailableAll regions |
||||
